FDA Approved: DRONABINOL — Supplemental Application (Wellhouse Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for dronabinol submitted by Wellhouse Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)